Is Biocept, Inc. (BIOCQ) a Buy, Sell, or Hold?
OTC : BIOCQ
Biocept, Inc.
$0.0001 USD
$0 (0.0%)
- Volume
- 238
- Average Volume
- 731
- Market Capitalization
- $263
- P/E Ratio
- -0.01
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.10
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.97
Company Overview
OTC
Soon Kap Hahn
Medical - Diagnostics & Research
Healthcare
BIOCQ
50
US
USD
Liquidity Metrics
1.37
2.97
2.83
2.34
0.00
Sales & Valuation
$25.86M
0.02
0.03
-0.03
-24.94
Profitability
-$56.78
-$32.09M
-124.09%
-124.57%
-138.49%
-103.93%
P/E Metrics
-0.01
0.00
0.00
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
No financial score data available.
Key Metrics (TTM)
-$337.21K
-0.01
0.01
2.97
-138.49%
-117.56%
-13055.50%
-3126.98%
21 days
Company Executives
| Name | Title |
|---|---|
| Veena Singh | Senior Medical Director |
| Soon Kap Hahn | Founder |
| Pavel Tsinberg | Director of Technology Development |
Poll Results
No votes yet today — be the first to share your view!
About Biocept, Inc. (OTC:BIOCQ) Stock
Biocept, Inc., established in 1997 and based in San Diego, California, was a molecular oncology diagnostics firm. Its primary business involved the development and commercialization of exclusive clinical laboratory assays within the United States. These advanced tests were engineered to detect elusive tumor cells and cell-free tumor DNA (ctDNA) from both blood and cerebrospinal fluid (CSF) samples. The insights provided by Biocept's cancer assays were instrumental for healthcare professionals, allowing them to pinpoint specific cancer-causing genetic mutations. This capability helped identify suitable cancer patients for targeted therapies, whether at the point of initial diagnosis, during disease progression, or for continuous monitoring to uncover resistance mechanisms. The company offer ... ed diagnostic solutions for a variety of solid tumor cancers, such as breast, non-small cell lung (NSCLC), gastric, colorectal, prostate, pancreaticobiliary, and ovarian cancers. Furthermore, Biocept extended specialized testing services for CSF tumor cells, ctDNA, and ctRNA to a diverse group of medical specialists, including medical oncologists, neuro-oncologists, surgical oncologists, radiation oncologists, urologists, pulmonologists, and pathologists. It also supplied clinical trial and research assistance to pharmaceutical and biopharmaceutical companies, along with clinical research organizations. Biocept participated in collaborations, notably with CLEARED4 to create a system for overseeing COVID-19 testing requirements and results for its clientele. Another partnership with Protean BioDiagnostics, Inc. aimed to evaluate the proficiency of its Target Selector molecular assay in ascertaining EGFR status in NSCLC patients. However, Biocept, Inc. voluntarily initiated liquidation proceedings by filing for Chapter 7 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware on October 13, 2023.
Frequently Asked Questions
-
What is the current Biocept, Inc. (BIOCQ) stock price?
-
Biocept, Inc.(OTC:BIOCQ) stock price is $0.0001 in the last trading session. During the trading session, BIOCQ stock reached the peak price of $0.1 while $0.0001 was the lowest point it dropped to. The percentage change in BIOCQ stock occurred in the recent session was 0.0% while the dollar amount for the price change in BIOCQ stock was $0.
-
BIOCQ's industry and sector of operation?
-
The OTC listed BIOCQ is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.
-
Who are the executives of BIOCQ?
-
Veena Singh | Senior Medical Director
Soon Kap Hahn | Founder
Pavel Tsinberg | Director of Technology Development
|
| -
How many employees does BIOCQ have?
-
Number of BIOCQ employees currently stands at 50. BIOCQ operates from 9955 Mesa Rim Road, San Diego, CA 92121, US.
-
Link for BIOCQ official website?
-
Official Website of BIOCQ is: https://biocept.com
-
How do I contact BIOCQ?
-
BIOCQ could be contacted at phone #858 320 8200 and can also be accessed through its website. BIOCQ operates from 9955 Mesa Rim Road, San Diego, CA 92121, US.
-
How many shares of BIOCQ are traded daily?
-
The average number of BIOCQ shares traded daily for last 3 months was 731.
-
What is the market cap of BIOCQ currently?
-
The market value of BIOCQ currently stands at $263 with its latest stock price at $0.0001